Pyc.asx

Looks you are already a member. Please enter your pyc.asx to proceed.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets.

Pyc.asx

Driven to transform the lives of patients through a new generation of RNA therapeutics. PYC Therapeutics combines world-leading RNA therapeutic drug design with a revolutionary delivery technology based on a proprietary library of naturally derived Cell Penetrating Peptides CPPs to solve the delivery challenge associated with traditional RNA therapeutics. PYC has a initial focus on ophthalmology, neurodevelopmental and kidney diseases and aims to apply its platform technology to further indications. Our Platform is highly versatile and modular, offering broad potential across therapeutic areas. PYC's goal is to provide patients with no current treatment options a therapeutic that addresses the underlying cause of the disease. Truly Life-Changing Science. Latest Announcements. View all. We discover and develop RNA therapies to change the lives of patients with genetic diseases. Our Science. Disease areas PYC has a initial focus on ophthalmology, neurodevelopmental and kidney diseases and aims to apply its platform technology to further indications. Life-Changing Science PYC's goal is to provide patients with no current treatment options a therapeutic that addresses the underlying cause of the disease. Stay Connected. Subscribe to our mailing list:.

Westralian Gas and Power Pyc.asx. Please enter the code below.

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board. Corporate governance.

PYC Therapeutics Limited. PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of RNA therapeutics in Australia. About the company. It also focuses on the development of programs for kidney, neurodevelopmental, retinal, and central nervous system diseases. Revenue is forecast to grow Shareholders have been diluted in the past year. Significant insider selling over the past 3 months.

Pyc.asx

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company, which offers ribonucleic acid RNA therapeutics in patients with unmeet genetic diseases. The Company develops a pi peline of therapies, including two programs, which are focused on inherited eye diseases and preclinical discovery programs, which are focused on neurodegenerative and kidney diseases. Its preclinical, clinical, regulatory and corporate operations are based in San Diego, California. The Company's discovery and laboratory operations are located in Australia.

Kite surfing lessons maui

You might already have an ASX account with another platform. Novacoat Holdings Limited. Past Performance. Looks you are already a member. PYC has a initial focus on ophthalmology, neurodevelopmental and kidney diseases and aims to apply its platform technology to further indications. Latest Announcements. Murchison Metals Limited. Subscribe to our mailing list:. A verification email has been sent. Use our equities screener to discover other potential opportunities.

See all ideas.

Jun Two-Factor Authentication. Our Board. Show more Opinion link Opinion. PYC has a initial focus on ophthalmology, neurodevelopmental and kidney diseases and aims to apply its platform technology to further indications. Is PYC overvalued? Revenue is forecast to grow It may take a few minutes to update your subscription details, during this time you will not be able to view locked content. Average volume 1. You now have access to Intelligent Investor Free Insights. Why list on ASX.